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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYLgr5-expressing intestinal stemcells (ISCs) renew the adult gut epitheliumbyproducingmature villus cells (VCs); the transcriptional basis
for ISC functions remains unclear. RNA sequencing analysis identified transcripts modulated during differentiation of Lgr5+ ISCs into
VCs, with high expression of the intestine-restricted transcription factor (TF) gene Cdx2 in both populations. Cdx2-deleted mouse
ISCs showed impaired proliferation and long-term inability to produce mature lineages, revealing essential ISC functions. Chromatin
immunoprecipitation sequencing analysis of CDX2 in Lgr5+ ISCs, coupled with mRNA profiling of control and Cdx2/ ISCs, identified
features of CDX2 regulation distinct fromVCs.Most CDX2 binding in ISCs occurs in anticipation of future gene expression, but whereas
CDX2 primarily activates VC genes, direct ISC targets are activated and repressed. Diverse CDX2 requirements in stem and differentiated
cells may reflect the versatility of TFs that specify a tissue in development and control the same tissue in adults.INTRODUCTION
Intestinal stem cells (ISCs) produce diverse mature cell
types. The best characterized and most abundant ISC
pool consists of Lgr5+ cells at the crypt base (Barker et al.,
2007). These cells replicate daily, giving rise to highly
proliferative transit-amplifying (TA) progenitors, which
occupy higher crypt tiers and eventually produce termi-
nally differentiated villus cells (VCs), including absorptive
enterocytes and secretory (goblet and enteroendocrine)
cells. Lgr5+ ISCs contribute to all mature VC lineages for
months (Barker et al., 2007) and generate ‘‘organoids’’
that self-renew in culture (Sato et al., 2009). Other ISC
populations at different crypt positions replicate less
frequently, respond to tissue injury, and express markers
such as Bmi1, Hopx, Lrig1, and Tert (Clevers, 2013); Lgr5+
ISCs may co-express the same marker genes (Itzkovitz
et al., 2012; Mun˜oz et al., 2012). Indefinite self-renewal
and the potential to yield distinct daughter lineages require
particular transcriptional programs, but the transcription
factors (TFs) that drive them and the associated chromatin
states are insufficiently understood. Although knockout
mice have implicated several TFs, including ASCL2, KLF5,
and YY1, in control of various ISC functions (Nandan
et al., 2015; Perekatt et al., 2014; van der Flier et al.,
2009), their target genes and mechanisms remain unclear,
in part because it is difficult to isolate enough ISCs for
biochemical studies.
Using RNA sequencing (RNA-seq) to profile transcripts
in intestinal VCs and Lgr5+ ISCs, we observed that Cdx2,Stem Cell Ra homeobox TF gene implicated in gut epithelial develop-
ment (Gao et al., 2009; Grainger et al., 2010) and adult
enterocyte maturation (Verzi et al., 2010b), was highly
and almost equally expressed in both cell populations.
Conditional null mice revealed an autonomous prolifera-
tion deficit in Cdx2/ ISCs, and instead of producing
mature intestinal cell types, these cells formed undifferen-
tiated cystic structures in vivo and failed to generate proper
organoids in culture. Analysis of CDX2 occupancy in wild-
type ISCs, integrated with transcriptional changes in puri-
fied Cdx2/ ISCs, identified candidate direct target genes
and revealed a likely dual role in gene activation and repres-
sion.Most CDX2 binding in ISCs, however, occurs in antic-
ipation of gene activity in future cell generations.RESULTS
Differential Gene Expression in ISCs and VCs
To identify gene expression changes during intestinal
epithelial differentiation, we isolated Lgr5+ ISCs from
Lgr5EGFP-CreERT2 knockin mice (Lgr5KI) (Barker et al., 2007)
and mature VCs, comprised mainly of enterocytes. As
RNA-seq revealedmodest 30 bias in ISC samples, we applied
a 30 tag counting method to restrict FPKM (fragments
per kilobase of exon per million fragments mapped)
calculations to reads mapping to the most 30 1,000 bp of
each gene (Sigurgeirsson et al., 2014). We observed signifi-
cant differences in 3,317 VC-enriched and 2,889 ISC-
enriched transcripts (Q < 0.05, fold change > 2; Figure 1A).eports j Vol. 5 j 673–681 j November 10, 2015 j ª2015 The Authors 673
Figure 1. Loss of Cdx2 mRNA Selectively Impairs ISC Proliferation
(A) RNA-seq data from three biological replicates of Lgr5+ ISCs and VCs identify modulated genes. Grey, 6,752 genes with comparable
expression in both cell types; red, 3,317 VC-enriched genes; blue, 2,889 ISC-enriched genes (>2-fold; Q < 0.05). Markers of enterocytes or
goblet cells (red), Lgr5+ ISCs (blue), and other ISC populations (green) are highlighted. Cdx2 is highly expressed in both cell types.
(B) Gene Ontology clusters of genes with >4-fold change in VCs and ISCs.
(C) CDX2 immunohistochemistry (IHC) in control and Cdx2E-Del mouse ileum 3 days after final TAM treatment, confirming complete
epithelial loss, including ISCs (magnified to right; arrows).
(D) Electron microscopy of Cdx2E-Del ileum confirms the presence of ISCs (blue) among Paneth (P) cells.
(E) KI67 IHC reveals loss of proliferation in ISCs (magnified in Inset), but not in TA cells.
(F) Fraction of crypts with at least one KI67+ ISC in different regions of control and Cdx2E-Del intestines (*p < 0.01; ***p < 0.0001; t test).
The average number of KI67+ TA cells is not significantly altered. At least 30–50 crypts were counted in each of at least four biological
replicates.
Scale bars represent 50 mm (C and E), 20 mm (inset in E), and 2 mm (D).VC-enriched genes included enterocyte (Sis, Alpi/Akp3, Lct,
Fabp1) and goblet-cell (Muc2, Tff3) markers, while genes
such as Lgr5, Ascl2, Axin2, Myc, and Olfm4 were enriched
in ISCs (Figure 1A). Genes enriched >4-fold in ISCs
belonged in Gene Ontology terms related to cell-cycle
control, protein translation, and DNA replication, while
VC-enriched terms included lipid metabolism, membrane
transport, and oxidation-reduction (Figure 1B), indicating
that the data are reliable. Genes previously ascribed to alter-
native ISC populations—Bmi1, Hopx, Lrig1, and Prom1—
were highly expressed in both Lgr5+ ISCs and VCs (Fig-
ure 1A), supporting recent reports that these markers are
not exclusive (Itzkovitz et al., 2012; Mun˜oz et al., 2012).
Levels of Cdx2, an intestine-restricted TF gene necessary674 Stem Cell Reports j Vol. 5 j 673–681 j November 10, 2015 j ª2015 Thefor enterocyte maturation (Verzi et al., 2010b), were almost
as high in purified ISCs as in VCs (Figure 1A); immuno-
staining confirmed CDX2 expression in ISCs (Figure 1C).
Loss of CDX2 Markedly and Selectively Impairs ISC
Proliferation and Differentiation
To investigate a possibly separate CDX2 role in ISCs, we
examined Cdx2Fl/Fl;Villin-CreERT2 mice, where tamoxifen
(TAM) deletes Cdx2 in all small intestine epithelial cells
(Cdx2E-Del for epithelium deleted; Figure 1C). Although
ISCs with characteristic ultrastructural features were pre-
sent at the crypt base (Figure 1D), the number of crypts
with at least one KI67+ ISC was reduced throughout the
Cdx2E-Del small intestine, most significantly in the ileumAuthors
Figure 2. CDX2 Is Required for Lgr5+ ISC
Proliferation and Differentiation
(A) Serial tissue sections from control and
Cdx2ISC-Del intestines 4 days after TAM,
showing CDX2 loss in patches of LGR5-
GFP-Cre+ crypts (dashed areas magnified
to right). CDX2 is retained in some Paneth
cells in these crypts (arrows).
(B) Representative cell-cycle analysis of
Lgr5+ ISCs from control and Cdx2ISC-Del pro-
ximal small bowel. Flow cytometry of Cdx2Del
ISCs stained with Hoechst dye reveals
accumulation in G1, with a reduced S-phase
fraction.
(C) Cdx2Fl/Fl;Lgr5KI;R26RYFP and control mice
were injected with TAM for 5 days and
examined at the indicated times. YFP
fluorescence at 10 days indicates that
traced Cdx2Del crypts retain some ability
to contribute to villi. At 90 days, tracing
in Cdx2ISC-Del intestines is confined to cysts
(asterisk) and unproductive crypts.
(D) H&E staining of the cysts shows luminal
debris. IHC confirms that traced cysts lack
CDX2 and are surrounded by CDX2+ crypts
that did not express the Lgr5KI allele.
Alkaline phosphatase (AP), periodic acid-
Schiff (PAS), and Alcian blue (AB) staining
show absence of mature enterocytes and
goblet cells in the cystic structures.
Scale bars represent 30 mm (A and D) and
50 mm (C). See also Figure S1.(Figures 1E and 1F), where CDX2 levels are normally high-
est (James andKazenwadel, 1991). This defect was confined
to crypt base ISCs; TA cells in higher tiers showed a normal
mitotic fraction (Figures 1E and 1F).
Cdx2Fl/Fl;Lgr5KI mice (Cdx2ISC-Del for ISC deleted) showed
CDX2 loss from all GFP+ crypts after TAM treatment (Fig-
ure 2A). As Lgr5KI mice are mosaic (Barker et al., 2007),
many crypts retained CDX2 in all cells, and because Paneth
cells do not express Lgr5 (Barker et al., 2007) and turn
over slowly (Ireland et al., 2005), they retained CDX2
(Figure 2A). In the proximal small intestine, where mosaic
Lgr5KI expression is highest (Barker et al., 2007), we
observed fewer LGR5-GFPHI cells in S-phase and more cells
in G1 (Figure 2B). Thus, independent measures reveal a
significant defect in replication of Cdx2 null ISCs. BecauseStem Cell RCDX2 is expressed only in epithelial cells and not in the
lamina propria, this defect must be cell autonomous.
Intact TA cell replication suggested that early events
following ISC differentiation may not require CDX2. To
test this possibility, we crossed a Rosa26lox-STOP-lox-YFP allele
(R26RYFP [Srinivas et al., 2001]) onto the Cdx2Fl/Fl;Lgr5KI
background to enable lineage tracing. After treating mice
with TAM, we followed YFP expression serially (Figure 2C),
noting again that mosaic Lgr5KI expression would delete
Cdx2 and activate Yfp in a minority of crypts. As TAM in-
duction of the Lgr5-CreERT2 irreversibly marks cells with
YFP, continuous Lgr5 expression is not required to monitor
the lineage tracing. Ten days later, YFPwas present in crypts
and villi in control (Cdx2+/+;Lgr5KI;R26RYFP) and, at slightly
lower frequency, in Cdx2ISC-Del mice (Figure 2C). However,eports j Vol. 5 j 673–681 j November 10, 2015 j ª2015 The Authors 675
starting at 1 month and continuing for at least 6 months
after Cre activation, YFP expression in Cdx2ISC-Del intes-
tines was confined to crypts and cystic inclusions, and
never detected in villi (Figures 2C, S1A, and S1B). These
cysts, similar to those previously noted in Cdx2/ crypts
(Stringer et al., 2012), showed total absence of CDX2 and
of mature VC features such as alkaline phosphatase, which
marks enterocytes, or avidity for periodic acid-Schiff or
Alcian blue, which marks goblet cells (Figure 2D). Cells
lining the cysts had a cuboidal morphology, with round
nuclei (Figure S1C); EZR and NHERF localization indicated
intact apico-basal polarity (Figure S1D). LGR5-GFP expres-
sion was typically confined to one side of the cysts, near
proliferating TA-like cells, which is reminiscent of normal
crypt organization, and non-replicating cells commonly
were sloughed from the upper cyst wall, collecting as
luminal debris (Figure S1E). Thus, Cdx2Del ISCs proliferate
poorly, and although they spawn replication-competent
TA cells, maturation of their progeny is severely impaired.
Of note, intestinal crypt cells also express CDX1 (James
and Kazenwadel, 1991), a homolog with redundant activ-
ity in TA cells (Verzi et al., 2011). The specific defects
in Cdx2/ crypts reveal a crucial, non-redundant require-
ment in the stem cell compartment.
Lgr5+ ISCs generate organoid bodies when cultured in
defined media (Sato et al., 2009). To test whether Cdx2
loss affects this property, we treated Cdx2Fl/Fl;Villin-CreERT2
intestinal crypts with TAM in culture. Eight days later,
organoids from control Cre crypts were large and showed
crypt-like evaginations, whereas Cdx2-deficient crypts
formed few organoids; when present, these were small
and spherical, with few protrusions, and totally lacked
CDX2, but showed signs of multilineage differentiation
in the form of mature enterocyte and goblet cell markers
(Figures S1F–S1H). Thus, significant deficits in cell replica-
tion, lineage tracing, organoid formation, and generation
of mature intestinal cells reveal a CDX2 requirement in
ISC functions, ostensibly distinct from CDX2’s activity
in mature enterocytes or its redundant functions with
CDX1 in TA cells.
CDX2 Loss in ISCs Affects Genes that Regulate Cell
Proliferation
To identify genes dysregulated in CDX2 null ISCs, we
isolated GFP+ cells from Cdx2ISC-Del and control (Cdx2+/+;
Lgr5KI) intestinal crypts after 4 days of TAM exposure.
RNA-seq confirmed loss of most transcripts containing
loxP-flanked exon 2 in Cdx2Del ISCs (Figure S2A). In addi-
tion, 412 transcripts were decreased and 639were increased
at least 1.5-fold (Q < 0.05; Figure 3A). Genes with reduced
expression were enriched for terms related to mitosis,
consistent with reduced ISC replication, whereas genes
that increased in expressionwere enriched for terms related676 Stem Cell Reports j Vol. 5 j 673–681 j November 10, 2015 j ª2015 Theto drug and lipid metabolism (Figure 3B). Because CDX2
may mediate intestine-specific Wnt signaling (Verzi et al.,
2010a), we assessed the consequences of CDX2 loss on
a curated list of 203 intestinal Wnt target genes (van de
Wetering et al., 2002). These transcripts showed higher
average expression in control ISCs than in VCs, but average
expression was unperturbed in Cdx2Del ISCs (Figure 3C);
only 24 individual Wnt target genes were significantly
affected, with no obvious pattern (Figure S2B). Although
217 CDX2 binding sites contain a TCF/LEF motif (Fig-
ure 3C), the data suggest that CDX2 activity in ISCs is
largely Wnt independent, possibly compensated by the
partially redundant factor CDX1. We also probed arrays
containing 39 phosphorylated receptor tyrosine kinases
with protein lysates from purified control and Cdx2Del
ISCs. Strong phosphorylation signals for the epidermal
growth factor receptor (EGFR) and ERBB2 were reproduc-
ibly lower in Cdx2Del ISCs (Figure 3D). Together, these find-
ings reveal that CDX2 controls select ISC genes, some of
which mediate cell surface events in EGFR signaling.
A single dominant target gene is, however, unlikely to
explain CDX2 requirements in vivo. We therefore sought
to determine features of CDX2 regulation by mapping its
binding sites in ISCs.
Gene Targets of CDX2 Regulation in ISCs
In contrast with >12,000 sites previously detected in VCs
(Verzi et al., 2013), chromatin immunoprecipitation
sequencing (ChIP-seq) on purified wild-type Lgr5+ ISCs
identified 2,371 regions enriched for CDX2 binding (e.g.,
Figure 3E). The distribution of CDX2 binding sites in pro-
moters and distant sites in Lgr5+ ISCs resembled that in
VCs (Figure 3F); these areas showed evolutionary conserva-
tion (Figure S2C), and the CDX2 consensus motif was the
most recurring (Figure 3G). Moreover, binding sites in
ISCs coincided with presence of H3K4me2 (Kim et al.,
2014) and H3K27ac (Sheaffer et al., 2014) histone marks,
indicating that they represent bona fide active cis-regulato-
ry elements (Figures 3E and 3H).
Most CDX2 binding sites in VCs (Verzi et al., 2013) gave
weak or no signals in Lgr5+ ISCs (Figure 4A), reflecting
either truly absent binding or the challenges inherent in
detecting low-level occupancy. Conversely, at least 60%
of CDX2 binding sites in purified ISCs were also evident
in mature VCs (Figures 4A and 4B), likely representing
occupancy at genes expressed in both cell types or ISC
binding in anticipation of VC activity. The remaining
1,000 binding sites in Lgr5+ ISCs were considerably
weaker or absent in VCs (Figures 4A and 4B) andmay repre-
sent sites of ISC-specific activity. To distinguish among
these possibilities, we first assigned CDX2 binding sites to
the nearest gene within 30 kb. Of the 1,156 genes showing
at least 1 binding site in ISCs, 883 genes were also occupiedAuthors
Figure 3. Genes Perturbed by CDX2 Loss and Delineation of CDX2 Binding in ISCs
(A) RNA-seq data from isolated control and Cdx2Del ISCs, using three biological replicates. 639 transcripts are elevated in Cdx2/ ISCs
(green), and 412 transcripts are reduced (blue). Grey, genes with <1.5-fold change or Q > 0.05.
(B) Gene Ontology cluster enrichment among genes reduced or increased in Cdx2Del ISCs.
(C) Average RNA-seq FPKM values of 203 intestinal Wnt target genes in control VCs and ISCs and in Cdx2Del ISCs. Significance was assessed
by a t test. Bottom: the TCF4 motif found in 217 CDX2 binding sites.
(D) Phospho-receptor tyrosine kinase arrays probed with lysates from purified control or Cdx2Del ISCs. Signals for pEGFR and pERBB2 are
reduced in Cdx2Del ISCs.
(E) ChIP-seq signals for CDX2, H3K4me2, and H3K27ac near the Oat and Magohb genes; the y axis represents aligned ChIP-seq tag counts.
(F) Distribution of CDX2 binding sites among genomic regions is similar in ISCs and VCs.
(G) The consensus CDX2 motif is the most enriched (Z score: 41.34) in CDX2-bound sites.
(H) Heatmaps of ChIP signals for CDX2, H3K4me2, and H3K27ac around CDX2 binding sites in purified ISCs. Right: overlap of CDX2 binding
sites with called H3K4me2 and H3K27ac peaks, which underestimate the overlap evident in heatmaps.
See also Figure S2 and Table S1.in VCs (Figure 4C).We first approached these findings from
the perspective of genes with nearby CDX2 binding (Fig-
ure 4D). The small proportion of genes bound only in
ISCs was similar among ISC-enriched and VC-expressed
genes, whereas genes bound only in VCs or in both ISCs
and VCs were more highly expressed in VCs. ApproachingStem Cell Rthe data next from the perspective of genes differentially
expressed in ISCs and VCs (Figure 4E), we see that villus-
expressed genes are enriched for CDX2 binding in both
ISCs and VCs. In contrast, genes with unique CDX2 bind-
ing in ISCs are distributed across the expression spectrum
(Figure 4E). Notably, genes bound in both ISCs and VCseports j Vol. 5 j 673–681 j November 10, 2015 j ª2015 The Authors 677
Figure 4. Contrasting Features of CDX2 Binding in ISCs and VCs
(A) Number of CDX2 binding sites identified exclusively in ISCs (blue), only in VCs (red), or in both cell types withR1-bp overlap (purple).
(B) Illustrative data traces for CDX2 binding sites of each class (arrows). y axis, ChIP-seq tag counts; x axis: genome coordinates.
(C) Among the 1,156 genes that bind CDX2 within 30 kb in ISC, 273 are bound only in ISCs and 883 are also bound in VCs.
(D) Genes bound only in VCs (red) or in both VCs and ISCs (purple) are mostly expressed in VCs (***p < 0.0001; c2 test); genes bound only
in ISCs (blue) are not enriched for expression in either compartment.
(E) Genes ordered by the degree of differential expression in ISCs and VCs (>2-fold, Q < 0.05, from data in Figure 1A) were binned
into groups of 100 (blue–red heatmap). Yellow heatmaps represent average number of CDX2 binding sites in VCs only, in ISCs only, or in
both populations within 30 kb of genes in each bin, normalized for average CDX2 binding across all expressed genes.
(F) CDX2 binds near similar proportions of genes (p = 0.57, Fisher’s exact test) that show reduced or increased transcript levels in
Cdx2/ ISCs.
(G) Genes ordered by the degree of differential expression in Cdx2Del versus control ISCs (from data in Figure 3A) were binned into groups of
25 (blue–green heatmap). Below: average number of CDX2 binding sites in ISCs within 30 kb of the genes in each bin, divided by the
average CDX2 binding across all expressed genes.
(H) CDX2 binding data at representative upregulated (Hmgcs2 and Hpgd) and downregulated (Fgfpb1 and Vdr) genes. Right: heatmap of
corresponding RNA-seq data.
Scale bars represent 1 kb (green line in B) and 5 kb (H). See also Figures S2 and S3.are highly enriched for ‘‘transcriptional activity’’ (Gene
Ontology cluster enrichment score: 3.38) and include
Cdx1/2, Gata4/6, Hnf4a/g, Hnf1b, Klf5, Vdr, and Yy1 (Fig-
ure S2D). Thus, much of the CDX2 binding in ISCs persists
in differentiated cells, near genes that are highly expressed
in the latter. This binding thus precedes future VC activity
rather than serving functions unique to ISCs.
Because direct transcriptional targets in ISCs should
show both CDX2 binding and perturbed mRNA levels in678 Stem Cell Reports j Vol. 5 j 673–681 j November 10, 2015 j ª2015 Theits absence, we considered ISC binding in the light of differ-
ential gene expression in Cdx2ISC-Del ISCs. Most CDX2-
bound genes were unaffected in transcript levels, implying
that CDX2 is dispensable for their regulation. Among the
137 genes with CDX2 binding and altered mRNA levels
in Cdx2/ ISCs, 80 genes were increased and 57 were
decreased (Figures 4F–4H and S3). In VCs, by contrast,
CDX2 binds almost exclusively at loci that are downregu-
lated upon Cdx2 loss (Verzi et al., 2013). Thus, whereasAuthors
CDX2 predominantly activates VC genes, in ISCs it may
activate some genes and repress others.DISCUSSION
We demonstrate an early, cell-autonomous role for CDX2
in promoting ISC replication in vivo and Cdx2/ cells’
steadily diminished ability to produce differentiated
VCs. Previous studies of Cdx2Del cysts and organoid cul-
tures have suggested that Cdx2 loss activates stomach
epithelial marker genes and hence compromises intestinal
identity (Hryniuk et al., 2012; Simmini et al., 2014;
Stringer et al., 2012). However, our RNA-seq analysis of
Cdx2Del ISCs revealed elevated levels of only 2 of 11
common stomach-specific transcripts (Table S1), and
we did not detect CDX2 binding near these genes in
ISCs. Thus, gastric transdifferentiation does not seem to
be a prominent early feature of Cdx2/ ISCs, though
other target genes, including transcriptional and epige-
netic regulators, may perturb stomach-specific genes
over time.
Feedback mechanisms for ISC homeostasis are poorly
understood. By revealing different CDX2 requirements in
various crypt cell populations, our findings provide useful
insights. First, combined loss of CDX1 andCDX2markedly
affects TA cell replication (Verzi et al., 2011), but these cells
withstand loss of CDX2 alone. Second, the outcome when
Lgr5+ ISCs are incapacitated by CDX2 loss—but remain
viable—differs from that when Lgr5+ ISCs are killed using
Diphtheria toxin. Whereas reserve Bmi1+ ISCs are rapidly
recruited into an active role in the latter case (Tian et al.,
2011), Cdx2/ cysts persist for months, avoiding replace-
ment by CDX2+ cells, such as the progeny of quiescent
ISCs in Cdx2ISC-Del mice. One possibility is that leaky
Lgr5-Cre expression in quiescent ISCs triggered deletion
of Cdx2, which is also required in this ISC pool, but Lgr5
expression is notably absent in quiescent ISCs in Lgr5KI
mice (Barker et al., 2007; Tian et al., 2011). We therefore
favor the alternative explanation that persistent ISCs and
TA cells in Cdx2ISC-Del intestines are sufficient to avoid the
feedback signals that elicit compensatory activity from
quiescent ISCs.
This study advances understanding of CDX2 mecha-
nisms in ISC maintenance and differentiation. CDX2 oc-
cupies hundreds of genomic sites exclusively in ISCs and
thousands of additional sites in VCs. Unlike in VCs, how-
ever, CDX2 binding in ISCs correlates poorly with ISC-ex-
pressed genes. Instead, much of it overlaps with binding
sites in VCs, occurring at genes activated in subsequent
cell generations. Moreover, while CDX2 behaves almost
exclusively as a transactivator in VCs, it may directly
activate or repress ISC genes. This could occur through in-Stem Cell Rteractions with different co-factors, alternative post-trans-
lational modifications, or differential chromatin access.
Studies of other TFs and chromatin in purified ISCs are
necessary to resolve these possibilities.EXPERIMENTAL PROCEDURES
Mice
Cdx2Fl/Fl, Villin-CreERT2, Lgr5-EGFP-IRES-CreERT2, and Rosa26-lox-
STOP-lox-YFP mice were described previously (Barker et al., 2007;
el Marjou et al., 2004; Srinivas et al., 2001; Verzi et al., 2010b).
For recombination of conditional alleles, mice were injected intra-
peritoneally for 4–5 days with 1–2 mg tamoxifen (Sigma). All pro-
cedures followed protocols approved by an Institutional Animal
Care and Use Committee.Epithelial Cell Isolation
Crypts from the proximal small intestine were isolated by scraping
off villi and incubating in 5 mM EDTA. Crypts were trypsinized
into a single cell suspension and passed through a FACSAria III in-
strument (BD Biosciences) to sort single live LGR5-GFPHI cells.
Alternatively, intestines were incubated in EDTA and VCs were
captured using 70-mm filters.RNA-Seq
More than 105 control ISCs, Cdx2Del ISCs, or VCs were collected
from single mice, and isolated RNA was sequenced (see the
Supplemental Experimental Procedures for RNA isolation, library
preparation, sequencing, and analysis protocols). Three biological
replicates for each condition were compared, and significantly
dysregulated genes were analyzed for Gene Ontology term
enrichment.Histology
Intestine segments were fixed overnight in 4% paraformaldehyde
at 4C, and they were dehydrated for paraffin embedding or incu-
bated overnight in 30% sucrose and frozen in optimum cutting
temperature (OCT) compound (Tissue-Tek). 5-mmparaffin sections
were stained with H&E, alkaline phosphatase, alcian blue, periodic
acid-Schiff, or specific antibodies (Ab) to CDX2, KI67, GFP, EZR, or
NHERF (more information in the Supplemental Experimental Pro-
cedures). 10-mm cryosections were mounted with DAPI to image
native YFP.ChIP-Seq
53 106 LGR5-GFPHI ISCs were pooled from several mice and cross-
linked in 1% formaldehyde at room temperature for 25 min, fol-
lowed by lysis, sonication, and immunoprecipitation with 3 mg
CDX2 Ab (Bethyl Laboratories). See the Supplemental Experi-
mental Procedures for ChIP, sequencing, and analysis protocols.
CDX2 binding sites were identified from aligned sequencing reads
and assigned to the single nearest gene within 30 kb. Published
ChIP-seq data were analyzed in parallel.
Additional details of protocols can be found in the Supplemental
Experimental Procedures.eports j Vol. 5 j 673–681 j November 10, 2015 j ª2015 The Authors 679
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